Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wellsted

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of Nephrology|December 20, 2023
Impact of COVID-19 on patient experience of kidney care: a rapid reviewLucy Mackintosh, Paula Ormandy, Amanda Busby, et al.
Trials|November 26, 2021
The Reflective Fostering Programme-improving the wellbeing of children in care through a group intervention for foster carers: a randomised controlled trialNick Midgley, Karen Irvine, Beth Rider, et al.
BMC Nephrology|December 4, 2023
Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centresLucy Mackintosh, Amanda Busby, Ken Farrington, et al.
Comprehensive Psychiatry|January 29, 2023
Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trialNaomi A Fineberg, Eduardo Cinosi, Megan V A Smith, et al.
Health Technology Assessment (Winchester, England)|December 22, 2024
Energetic activity for depression in young people aged 13-17 years: the READY feasibility RCTMegan Smith, Ryan James, Neil Howlett, et al.
Journal of Nephrology|January 12, 2025
Depression and anxiety in people with kidney disease: understanding symptom variability, patient experience and preferences for mental health supportJoseph Chilcot, Christina J Pearce, Natalie Hall, et al.
International Clinical Psychopharmacology|August 17, 2018
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorderNaomi A Fineberg, David S Baldwin, Lynne M Drummond, et al.
Pilot and Feasibility Studies|December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
Comprehensive Psychiatry|February 17, 2026
Habit as a therapeutic component in psychological treatment for obsessive-compulsive disorder: A randomised controlled feasibility studyAna Maria Frota Lisboa Pereira de Souza, Davis Mpavaenda, Paula Banca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Nephrology|December 20, 2023
Impact of COVID-19 on patient experience of kidney care: a rapid reviewLucy Mackintosh, Paula Ormandy, Amanda Busby, et al.
Trials|November 26, 2021
The Reflective Fostering Programme-improving the wellbeing of children in care through a group intervention for foster carers: a randomised controlled trialNick Midgley, Karen Irvine, Beth Rider, et al.
BMC Nephrology|December 4, 2023
Impact of the COVID-19 pandemic on services for patients with chronic kidney disease: findings of a national survey of UK kidney centresLucy Mackintosh, Amanda Busby, Ken Farrington, et al.
Comprehensive Psychiatry|January 29, 2023
Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trialNaomi A Fineberg, Eduardo Cinosi, Megan V A Smith, et al.
Health Technology Assessment (Winchester, England)|December 22, 2024
Energetic activity for depression in young people aged 13-17 years: the READY feasibility RCTMegan Smith, Ryan James, Neil Howlett, et al.
Journal of Nephrology|January 12, 2025
Depression and anxiety in people with kidney disease: understanding symptom variability, patient experience and preferences for mental health supportJoseph Chilcot, Christina J Pearce, Natalie Hall, et al.
International Clinical Psychopharmacology|August 17, 2018
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorderNaomi A Fineberg, David S Baldwin, Lynne M Drummond, et al.
Pilot and Feasibility Studies|December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
Comprehensive Psychiatry|February 17, 2026
Habit as a therapeutic component in psychological treatment for obsessive-compulsive disorder: A randomised controlled feasibility studyAna Maria Frota Lisboa Pereira de Souza, Davis Mpavaenda, Paula Banca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Pageof 11